Corticosteroid dosing and opioid use are high in patients with SLE and remain elevated after belimumab initiation: a retrospective claims database analysis
Objectives To investigate corticosteroid and opioid use among patients with SLE and to examine the impact of belimumab initiation on the use of other SLE therapies.Methods We identified adult patients with SLE (International Classification of Diseases, 9th Revision/10th Revision 710.0 and M32) betwe...
Saved in:
| Main Authors: | Karen H Costenbader, Jianmin Wu, Julie A Birt, Kirstin Griffing, Natalia Bello, Nicole Princic, Isabelle Winer, Carolyn R Lew |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/7/1/e000435.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Outcomes of Patients with SLE Treated with Belimumab, Without Versus With Prior Immunosuppressant Use: a US Claims Database Study
by: Karen H. Costenbader, et al.
Published: (2025-06-01) -
Real-world treatment patterns, healthcare resource utilisation and costs in patients with SLE in the USA
by: Karen Costenbader, et al.
Published: (2024-12-01) -
Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report
by: Tineke Kraaij, et al.
Published: (2025-02-01) -
Alternation of anti-NMDA receptor subunit GluN2 antibody in a patient with SLE who promptly developed anxiety after belimumab
by: Yoshiyuki Arinuma, et al.
Published: (2025-06-01) -
Epidemiology of SLE in Italy: an observational study using a primary care database
by: Pietro Ferrara, et al.
Published: (2024-05-01)